184 related articles for article (PubMed ID: 23340833)
1. The association between hepatitis B virus infection and disease activity, synovitis, or joint destruction in rheumatoid arthritis.
Zou CJ; Zhu LJ; Li YH; Mo YQ; Zheng DH; Ma JD; Ou-Yang X; Pessler F; Dai L
Clin Rheumatol; 2013 Jun; 32(6):787-95. PubMed ID: 23340833
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of tumor necrosis factor receptor-associated factor 6 correlated with synovitis severity in rheumatoid arthritis.
Zhu LJ; Dai L; Zheng DH; Mo YQ; Ou-Yang X; Wei XN; Shen J; Zhang BY
Arthritis Res Ther; 2012 Jun; 14(3):R133. PubMed ID: 22656185
[TBL] [Abstract][Full Text] [Related]
3. Presence of hepatitis B virus in synovium and its clinical significance in rheumatoid arthritis.
Chen YL; Jing J; Mo YQ; Ma JD; Yang LJ; Chen LF; Zhang X; Yan T; Zheng DH; Pessler F; Dai L
Arthritis Res Ther; 2018 Jun; 20(1):130. PubMed ID: 29921328
[TBL] [Abstract][Full Text] [Related]
4. Synovial infiltration with CD79a-positive B cells, but not other B cell lineage markers, correlates with joint destruction in rheumatoid arthritis.
Mo YQ; Dai L; Zheng DH; Zhu LJ; Wei XN; Pessler F; Shen J; Zhang BY
J Rheumatol; 2011 Nov; 38(11):2301-8. PubMed ID: 22002013
[TBL] [Abstract][Full Text] [Related]
5. Joint damage is amplified in rheumatoid arthritis patients with positive thyroid autoantibodies.
Chen YL; Lin JZ; Mo YQ; Liang JJ; Li QH; Zhou CJ; Wei XN; Ma JD; Yang ZH; Zheng DH; Dai L
PeerJ; 2018; 6():e4216. PubMed ID: 29312834
[TBL] [Abstract][Full Text] [Related]
6. [Hepatitis B virus infection status and clinical characteristics in patients with rheumatoid arthritis].
Zheng HW; Ouyang ZM; Pan J; Jia PW; Zou YW; Ma JD; Chen LF; Li QH; Wu T; Dai L
Zhonghua Yi Xue Za Zhi; 2024 Jan; 104(3):205-211. PubMed ID: 38220446
[No Abstract] [Full Text] [Related]
7. Low positivity rates for HBeAg and HBV DNA in rheumatoid arthritis patients: a case-control study.
Jia Y; Zhang J; Mo L; Ju B; Hu N; Wang Y; Wang P; Zheng J; He L; Wang J
BMC Infect Dis; 2022 Jun; 22(1):570. PubMed ID: 35751011
[TBL] [Abstract][Full Text] [Related]
8. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
[TBL] [Abstract][Full Text] [Related]
9. [Expression of peroxisome proliferator-activated receptor-gamma coactivator 1β in synovium in patients with rheumatoid arthritis and its clinical significance].
Wei XN; Zhang XP; Yang LJ; Jing J; Wang JW; Wu T; Ma JD; Lin JZ; Zheng DH; Dai L
Zhonghua Yi Xue Za Zhi; 2021 Feb; 101(5):327-332. PubMed ID: 34645250
[No Abstract] [Full Text] [Related]
10. Disease Characteristics and Change in Arthritis Activity according to Treatment in Hepatitis B Surface Antigen-positive Rheumatoid Arthritis Patients: a Retrospective Chart Review Study.
Eun Y; Kim IY; Jeong H; Kim H; Lee J; Choi MS; Koh E; Cha HS
J Korean Med Sci; 2018 Jun; 33(23):e168. PubMed ID: 29853822
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis.
Harigai M; Winthrop K; Takeuchi T; Hsieh TY; Chen YM; Smolen JS; Burmester G; Walls C; Wu WS; Dickson C; Liao R; Genovese MC
RMD Open; 2020 Feb; 6(1):. PubMed ID: 32098857
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of HBV reactivation risk in rheumatoid arthritis patients who received conventional disease-modifying antirheumatic drugs.
Tan J; Zhou J; Zhao P; Wei J
Clin Rheumatol; 2012 Aug; 31(8):1169-75. PubMed ID: 22544263
[TBL] [Abstract][Full Text] [Related]
14. Reactivation of hepatitis B virus infection following rituximab treatment in HBsAg-negative, HBcAb-positive rheumatoid arthritis patients: A long-term, real-world observation.
Chen YM; Chen HH; Huang WN; Chen YH; Hsieh TY; Yang SS; Lan JL; Chen DY
Int J Rheum Dis; 2019 Jun; 22(6):1145-1151. PubMed ID: 31117160
[TBL] [Abstract][Full Text] [Related]
15. Safety of Tocilizumab in Rheumatoid Arthritis Patients with Resolved Hepatitis B Virus Infection: Data from Real-World Experience.
Ahn SS; Jung SM; Song JJ; Park YB; Park JY; Lee SW
Yonsei Med J; 2018 May; 59(3):452-456. PubMed ID: 29611409
[TBL] [Abstract][Full Text] [Related]
16. Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and/or nonbiological disease-modifying antirheumatic drugs.
Mori S
Mod Rheumatol; 2011 Dec; 21(6):621-7. PubMed ID: 21528424
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohorts.
Tamori A; Koike T; Goto H; Wakitani S; Tada M; Morikawa H; Enomoto M; Inaba M; Nakatani T; Hino M; Kawada N
J Gastroenterol; 2011 Apr; 46(4):556-64. PubMed ID: 21246383
[TBL] [Abstract][Full Text] [Related]
18. [Investigation of the risk of hepatitis B virus reactivation in arthritis patients undergoing anti-tumour necrosis factor alpha therapy].
Jin D; Tie N; Liu J; Zhao L; Hao D; Zhao Y
Zhonghua Nei Ke Za Zhi; 2015 Apr; 54(4):313-6. PubMed ID: 26268059
[TBL] [Abstract][Full Text] [Related]
19. [Detection of antibodies to cyclic citrullinated peptides and its clinical significance in patients with chronic hepatitis B virus infection].
Zhou RF; Liu XF; Chen Y; Wu F; Zeng AP; Cheng YJ
Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(22):1536-9. PubMed ID: 22944056
[TBL] [Abstract][Full Text] [Related]
20. Multidisciplinary Approach to Prevent de novo Hepatitis B in Patients with Rheumatoid Arthritis.
Watanabe R; Igarashi T; Takahashi T; Kondo H; Okazaki S; Kudo M; Ohyanagi M; Gamoh M
Tohoku J Exp Med; 2020 Oct; 252(2):133-141. PubMed ID: 33028756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
